Pegylated liposomal doxorubicin (PLD) in heavily pretreated epithelial ovarian cancer patients
dc.contributor.author | Gorumlu, Gurbuz | |
dc.contributor.author | Kucukzeybek, Yuksel | |
dc.contributor.author | Karabulut, Bulent | |
dc.contributor.author | Terek, Mustafa C. | |
dc.contributor.author | Uslu, Ruchan | |
dc.contributor.author | Sanli, Ulus A. | |
dc.contributor.author | Akman, Levent | |
dc.contributor.author | Ozsaran, Aydin | |
dc.contributor.author | Dikmen, Yilmaz | |
dc.contributor.author | Goker, Erdem | |
dc.date.accessioned | 2019-10-27T19:20:08Z | |
dc.date.available | 2019-10-27T19:20:08Z | |
dc.date.issued | 2006 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 31st Congress of the European-Society-for-Medical-Oncology -- SEP 29-OCT 03, 2006 -- Istanbul, TURKEY | en_US |
dc.description.sponsorship | European Soc Med Oncol | en_US |
dc.identifier.endpage | 172 | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.startpage | 172 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/38838 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000248078900556 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford Univ Press | en_US |
dc.relation.ispartof | Annals of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Pegylated liposomal doxorubicin (PLD) in heavily pretreated epithelial ovarian cancer patients | en_US |
dc.type | Conference Object | en_US |